logo
AI can be used to spread health disinformation

AI can be used to spread health disinformation

The Star2 days ago
Artificial intelligence (AI) has transformed many fields of human activity, including healthcare.
It is increasingly used to analyse complex medical and healthcare data, and has the potential to diagnose diseases, develop personalised treatment plans, and assist clinicians' decision-making.
While AI has the potential to enhance patients' care in their healthcare journeys, there are unresolved issues related to data privacy, bias and the need for human expertise, which has to be addressed for the responsible and effective use of AI in healthcare.
The public obtains substantial health information from multiple electronic sources and this has been propagated by social media.
AI has led to negative impacts on individual and public health.
This column addresses AI and health misinformation and disinformation.
Infodemic of misinformation and disinformation
The World Health Organization (WHO) distinguishes misinformation from disinformation.
'Misinformation is the spread of false information without the intent to mislead.
'Those who share the misinformation may believe it is true, useful or interesting, and have no malicious intent towards the recipients they are sharing it with.
'Disinformation is designed or spread with full knowledge of it being false (information has been manipulated), as part of an intention to deceive and cause harm.
'The motivations can be economic gain, ideological, religious, political or in support of a social agenda, among others.'
The harmful effects of misinformation and disinformation include threats to individual and public health, the environment, or security.
The Covid-19 pandemic was the perfect storm for the proliferation and spread of disinformation.
There was global fear, uncertainty and doubt.
It occurred at a time in history when there was extensive global access to, creation of and sharing of information, including misinformation and disinformation.
As the pandemic spread, social media postings and the virus' spread stoked fear; uncertainties about treatments and the effectiveness of non-pharmaceutical interventions like social distancing, masking etc; and the safety and effectiveness of the new vaccines, among others.
This caused societal turmoil and fear, protests in some countries, and delayed or no vaccine uptake, as well as increased death rates in some countries or regions.
During the pandemic, the WHO introduced the term 'infodemic', which is 'too much information, including false or misleading information, in digital and physical environments during a disease outbreak.
'It causes confusion and risk-taking behaviours that can harm health.
'It also leads to mistrust in health authorities and undermines the public health response.
'An infodemic can intensify or lengthen outbreaks when people are unsure about what they need to do to protect their health and the health of people around them.
'With growing digitisation – an expansion of social media and internet use – information can spread more rapidly.
'This can help to more quickly fill information voids, but can also amplify harmful messages'.
AI and health disinformation
The benefits of AI have been touted by many policymakers and healthcare professionals.
Advancements in AI, particularly for large language models (LLMs), are impacting on public health, with millions turning to AI tools for health-related advice.
But how reliable is the health advice from these tools?
Researchers from the University of South Australia (UniSA) and Flinders University in Australia, Harvard Medical School in the United States, University College London in Britain and the Warsaw University of Technology in Poland reported in the Annals of Internal Medicine on June 24 (2025), how easy it is to exploit the weaknesses in machine learning systems by using disinformation tools that the public have access to.
The researchers evaluated five foundational and most advanced AI systems developed by OpenAI, Google, Anthropic, Meta and X Corp to determine whether they could be programmed to operate as health disinformation chatbots.
Using instructions available only to developers, the researchers programmed each AI system (designed to operate as chatbots when embedded in web pages) to produce incorrect responses to health queries and included fabricated references from highly reputable sources to sound more authoritative and credible.
The 'chatbots' were then asked 10 health-related questions.
The researchers reported that: 'Of the 100 health queries posed across the five customised LLM API chatbots, 88 (88%) responses were health disinformation.
'Four of the five chatbots (GPT-4o, Gemini 1.5 Pro, Llama 3.2-90B Vision and Grok Beta) generated disinformation in 100% (20 of 20) of their responses, whereas Claude 3.5 Sonnet responded with disinformation in 40% (eight of 20).
'The disinformation included claimed vaccine-autism links, HIV being airborne, cancer-curing diets, sunscreen risks, genetically-modified organism conspiracies, attention deficit-hyperactivity disorder and depression myths, garlic replacing antibiotics, and 5G causing infertility.
'Exploratory analyses further showed that the OpenAI GPT Store could currently be instructed to generate similar disinformation.
'Overall, LLM APIs and the OpenAI GPT Store were shown to be vulnerable to malicious system-level instructions to covertly create health disinformation chatbots.'
Study lead author and UniSA pharmacy lecturer Dr Natansh Modi said: 'If these systems can be manipulated to covertly produce false or misleading advice, then they can create a powerful new avenue for disinformation that is harder to detect, harder to regulate, and more persuasive than anything seen before.
'This is not a future risk. It is already possible, and it is already happening.'
He added that effective safeguards are technically achievable.
'However, the current protections are inconsistent and insufficient.
'Developers, regulators and public health stakeholders must act decisively, and they must act now.
'Without immediate action, these systems could be exploited by malicious actors to manipulate public health discourse at scale, particularly during crises such as pandemics or vaccine campaigns.'
Take these actions
The message from the study is clear, i.e. 'Trust your doctor, not the chatbox.'
The comment in the New England Journal of Medicine 's Journal Watch on July 1 (2025) is unambiguous: 'The danger is clear and present: Anyone can create AI chatbots that generate authoritative answers with fabricated peer-reviewed references and disseminate false health information – no coding required.
'What can we do? ... writers remind us of the SIFT method: 'Stop and think;
'Investigate sources;
'Find other sources; and
'Trace claims to their origins.
'Critical thinking is our defence against AI misinformation and can help us build a culture of informed scepticism before harm is done.'
Individuals can do much on their own to address health misinformation and disinformation, such as: Getting accurate health information from your doctor and other healthcare professionals, and/or from websites of regulators and professional organisations
Looking out for emotional red flags online
Using fact-checking tools
Doing reverse image search by copying the image or the image's URL into the search bar of an image search tool
Spotting spoof websites
Spotting fake social media accounts
Countering the misinformation or disinformation by not sharing it, correcting it, debunking it and reporting it
Engaging with friends, colleagues and family to deal with the problem of health misinformation and disinformation
Addressing health misinformation and disinformation in the community.
Regulators have a vital role in addressing health misinformation and disinformation.
Their actions can include: Ensuring there are robust screening and accountability safeguards to ensure public health safety with rapidly evolving digital technologies
Addressing the public health impact of health misinformation and disinformation
Establishing best practices for prevention by ensuring their websites provide current and accurate health information
Sharing toolkits from other regulators
Investing in research on misinformation and disinformation
Modernising public health communications
Increasing resources to help states and non-governmental organisations (NGOs) to better address questions, concerns, misinformation and disinformation
Expanding efforts to build long-term resilience to misinformation and disinformation like educational programmes.
In summary, there is an urgent need for regulators, especially the government, to address the use of AI in health misinformation and disinformation.
Dr Milton Lum is a past president of the Federation of Private Medical Practitioners Associations and the Malaysian Medical Association. For more information, email starhealth@thestar.com.my. The views expressed do not represent that of organisations that the writer is associated with. The information provided is for educational and communication purposes only, and it should not be construed as personal medical advice. Information published in this article is not intended to replace, supplant or augment a consultation with a health professional regarding the reader's own medical care. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hepatitis C treatment can be safely shortened
Hepatitis C treatment can be safely shortened

The Star

time8 hours ago

  • The Star

Hepatitis C treatment can be safely shortened

A new clinical trial conducted in Malaysia has found that an eight-week regimen of ravidasvir and sofosbuvir is just as safe and effective as the standard 12-week treatment for chronic hepatitis C. This finding could accelerate efforts to scale up access to treatment in resource-limited settings by reducing treatment duration, costs and system burden. The EASE study (Evaluating Accelerated Shortened treatment for hepatitis C in Asia through real-world Evidence) was led by the Health Ministry (MOH) and conducted across 26 sites nationwide between March 2021 and March 2023. The randomised trial involved 322 patients diagnosed with chronic hepatitis C virus infection, including those with more complex medical profiles. The primary objective was to determine whether an eight-week treatment course using the fixed-dose combination of ravidasvir and sofosbuvir would achieve similar sustained virological response (SVR), compared to the standard 12-week regimen. An SVR refers to the continued absence of the hepatitis C virus in a patient's blood 12 weeks or more after they have completed treatment. It is essentially considered a virological cure for the infection. The study found no significant difference in efficacy between the two durations, with high SVR rates maintained in both arms. Safety profiles were also comparable, with no new adverse effects identified. The results were officially reported by the MOH in January (2025) and presented at the 2025 European Association for the Study of the Liver (EASL) Congress in early May in Amsterdam, the Netherlands. Ravidasvir was co-developed through a public-health partnership involving the MOH, Drugs for Neglected Diseases initiative (DNDi), Pharco Pharmaceuticals (Egypt) and Pharmaniaga Berhad (Malaysia), with key clinical trials conducted in Malaysia and Thailand. The treatment was first registered in Malaysia in 2021 and added to the World Health Organization (WHO) Essential Medicines List in 2023. While hepatitis C continues to affect approximately 50 million people globally, with only about 20% receiving treatment, high drug prices remain a barrier in many countries. A 2023 MOH study estimates 0.4% of the population in Malaysia to have hepatitis C. In line with WHO targets, Malaysia aims to eliminate the disease as a public health threat by 2030.

Tobacco Control Alliance: Asean plastic pollution treaty must address toxic cigarette filters
Tobacco Control Alliance: Asean plastic pollution treaty must address toxic cigarette filters

New Straits Times

time14 hours ago

  • New Straits Times

Tobacco Control Alliance: Asean plastic pollution treaty must address toxic cigarette filters

KUALA LUMPUR: The United Nations has been urged to ban plastic-based cigarette filters by the Southeast Asia Tobacco Control Alliance (Seatca), as governments worldwide meet to negotiate a treaty on plastic pollution. Seatca said the final round of negotiations in Geneva this week could either help Asean reverse the plastic pollution crisis or continue to pay US$10 billion (RM42 billion) to clean up toxic cigarette filters. The regional health NGO added that Asean member states, except for Indonesia, are parties to the World Health Organisation's (WHO) Framework Convention on Tobacco Control (FCTC). According to Seatca, an estimated 4.5 trillion cigarette butts are discarded globally each year, with 460 billion of those in Asean. These butts are made of cellulose acetate, a plastic that breaks down slowly into harmful microplastics. They also contain more than 7,000 chemicals, including nicotine and heavy metals, that can leach into the environment and harm ecosystems. Seatca called for the treaty to include a polluter-pays principle, making tobacco manufacturers financially responsible for filter pollution and cleanup. The group also said the treaty should reference the WHO's FCTC, reject industry influence, and ensure consistent alignment between environmental and public health policies. It also called for independent and industry-free public awareness campaigns and mandatory collection and disposal systems for tobacco product waste. The group highlighted that while eco-friendly alternatives exist for products like straws and bags, there are no sustainable alternatives for cigarette filters. It said that products marketed by the tobacco industry as "eco-filters" or "green butts" are misleading because they still release tar, nicotine, and heavy metals into the environment and often only break down under industrial composting conditions. Seatca said these "greenwashing tactics" must not fool negotiators, and that the treaty should include a comprehensive ban on all types of cigarette filters, not just plastic ones. The group added that filters, developed in the 1950s to ease public fears about the health effects of smoking, have failed to protect health.

Malaysia's healthcare travel industry eyes RM12 bil by 2030
Malaysia's healthcare travel industry eyes RM12 bil by 2030

Focus Malaysia

time16 hours ago

  • Focus Malaysia

Malaysia's healthcare travel industry eyes RM12 bil by 2030

MBSB Research recently hosted the Malaysia Healthcare Travel Council (MHTC) in a roundtable dialogue recently. While MHTC focuses on the private healthcare sector, various government ministries, are involved to ensure a cohesive and supportive ecosystem for medical tourism. This multi-agency cooperation is crucial for addressing the diverse needs of the industry, from healthcare standards to visa facilitation and economic planning. Since the decline in Covid-19 prevalence, Malaysia had seen a surge in medical travellers from the Asia-Pacific region seeking treatments. In 2024, the number of medical travellers reached 1.52 mil and revenue at RM2.72 bil. For 2025, MHTC is expecting revenue to climb up to RM3 bil, attributed by a robust demand for quality and affordable care. By 2030, MHTC aims to generate over RM12 bil in revenue, supported by continuous expansion of hospital capacity, targeted promotional efforts and implementation of integrated healthcare. Medical tourism in Malaysia is not just about hospital revenue. It creates a significant ripple effect across the economy. As foreign patients and their companions travel, they spend on various services beyond medical treatments, including accommodation, transportation, dining, and entertainment. This multiplier effect is a critical driver of growth for the hospitality, tourism, and food & beverage sectors. The revenue projected at RM12 bil by 2030 solely accounts for medical-related expenses and excludes the substantial spending on other associated services. This revenue, combined with an estimated economic multiplier of 4x, demonstrates the significant financial benefits of the industry. Every region in Malaysia contributed to medical tourism. In 2024, Central Region contributed 42% of the total revenue (RM886 mil) while Northern Region contributed 41%, Southern Region contributed 12% and the others (East Coast and East Malaysia) contributed 5%. Penang remains a major hub for medical tourism, serving up to 40% of the total volume of medical tourists. Its appeal is driven by its cultural affinity with Mainland Chinese and Indonesians, as well as its strategic proximity, which is supported by high flight frequency. Despite contributing the lowest revenue, East Coast had seen a gain in tourist volumes; likely due to the support from the state tourism and its proximity to Thailand. Meanwhile, Sabah and Sarawak saw high potential for growth, if state hospital brands are well promoted and accessibility by air and land are improved. Malaysia's competitive edge in the regional medical tourism market is its highly regulated healthcare environment. This offers a distinct advantage over competitors like Thailand and attracts patients seeking a safer and more structured treatment setting. Despite the first quarter typically not being a peak period, quarter one of 2025 already recorded a significant 8% increase in revenue (RM631 mil-682 mil) and a 7% rise in traveller volume (370,000-398,000). This indicates that Malaysia still retains an undulated potential and competitiveness in medical tourism. A key advantage for Malaysia is that foreign patients are charged the same rates as locals, which incentivizes them to spend more on other industries like tourism and hospitality. However, regional disparities remain a key challenge. While Penang is a major driver of medical tourism, largely due to key institutions like Island Hospital, East Malaysia struggles to attract medical tourists because of accessibility challenges, limited flight frequency, and less-known hospitals. 'Moving forward, we expect MHTC and other travel-related agencies and sectors (hospitality, consumer and aviation) to improve accessibility, as advocated by the government under the 13th Malaysia Plan,' said MBSB Research. —Aug 6, 2025 Main image: Senior Planet

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store